Damora Therapeutics(DMRA)
$21.60-0.45 (-2.04%)
DMRA
Damora Therapeutics stock drug pipeline
$21.60
At close:-0.45 (-2.04%)
Want to see DMRA full AI Analyst Report?
Damora Therapeutics (DMRA) Drug Pipeline
345 Followers
| Drug Name | Condition | Stage | Status | Study Name | Trial Start Date | Article |
|---|---|---|---|---|---|---|
| Ruxolitinib, Dmr-001 | Myeloproliferative Neoplasms (Mpns) | Phase I | Recruiting | Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of Mutant Calreticulin Targeted Antibodies in CALR-mutant Myeloproliferative Neoplasms | Sep 21, 2026 | ― |
| Drug Name | Stage | Condition | Status | Study Name | Trial Start Date | Article |
|---|---|---|---|---|---|---|
| Ruxolitinib, Dmr-001 | Phase I | Myeloproliferative Neoplasms (Mpns) | Recruiting | Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of Mutant Calreticulin Targeted Antibodies in CALR-mutant Myeloproliferative Neoplasms | Sep 21, 2026 | ― |
FAQ
What are the FDA phases for drug approval?
The FDA approval process for new drugs is divided into several phases: a. Preclinical testing b. Phase 1 – Safety and dosage c. Phase 2 – Effectiveness and side effects d. Phase 3 – Confirmation of effectiveness, monitoring of adverse reactions, and comparison with existing treatments e. Phase 4 – Post-marketing studies to track long-term safety and effectiveness
What is a clinical trial?
A clinical trial is a carefully designed study in which researchers test a drug, treatment, or medical device in people to evaluate its safety, effectiveness, and potential side effects. These trials are essential for determining whether a new treatment should be approved for widespread use.
What drugs does Damora Therapeutics, Inc. (DMRA) have in its pipeline
Damora Therapeutics DMRA is currently developing the following drugs: Ruxolitinib, Dmr-001. These drug candidates are in various stages of clinical development as the company works toward FDA approval.

